MACULAR DEGENERATION
Description
Symptoms
Clinical trialsEyeTech AMD Study - Macugen (FDA approved 12/04) Alcon Anecortave Acetate Risk Reduction Trial (AART)for AMD Regeneron VGFT-OD-0605 for Wet AMD - Spring 2007
Related FAQs
Related Images
Copyright © 1998-2009 Charles Retina Institute. Write to us at webmaster@charles-retina.com. HIPAA – Browsing for the Visually Impaired. Charles Retina Institute's HIPAA Notice of Privacy Practices | (as Acrobat PDF) | (as Word document) We strive to make our website universally accessible. Sitemap